Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mefloquine vs Sulphadoxine-Pyrimethamine for Malaria Prophylaxis in Pregnant HIV+ Patients
NCT02524444Phase 1Completed
- Start
- Sep 2015
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of mefloquine in malaria. Primary endpoint: Level of malaria parasitemia at delivery at 6 months. Started Sep 2015; status: completed.
02
Drugs
mefloquine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT02524444.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02524444.